ACTR-05. THE RANDOMIZED PHASE II ARTE TRIAL: BEVACIZUMAB PLUS HYPOFRACTIONATED RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

The addition of bevacizumab to temozolomide-based chemoradiotherapy (TMZ/RT→TMZ) prolonged progression-free survival (PFS), but not overall survival (OS) in patients with newly diagnosed glioblastoma in two double-blind phase III trials. Elderly and frail patients are underrepresented in most clinic...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Neuro-oncology (Charlottesville, Va.) Va.), 2017-11, Vol.19 (suppl_6), p.vi2-vi2
Hauptverfasser:	Weller, Michael, Tabatabai, Ghazaleh, Roelcke, Ulrich, Hottinger, Andreas, Joerger, Francisca, Schmid, Andrea, Plasswilm, Ludwig, Schrimpf, Daniel, Mancao, Christoph, Capper, David, Conen, Katrin, Hundsberger, Thomas, Caparrotti, Francesca, von Moos, Roger, Riklin, Christian, Felsberg, Jörg, Roth, Patrick, Jones, David, Pfister, Stefan M, Rushing, Elisabeth Jane, Abrey, Lauren, Reifenberger, Guido, Held, Leonhard, von Deimling, Andreas, Ochsenbein, Adrian, Wirsching, Hans-Georg
Format:	Artikel
Sprache:	eng
Schlagworte:	Abstracts
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!